Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-24T17:54:16.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removal of the government funding lapse notice from the page. The banner about potential information delays and links to operating status updates is no longer displayed.
    Difference
    0.3%
    Check dated 2025-11-17T17:49:40.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Only routine metadata updates are visible, such as updated last-update dates and timestamps; core content, eligibility criteria, endpoints, and participation instructions remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T12:31:08.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated biosimilar names and related dates; removed older date entries to reflect current information.
    Difference
    2%
    Check dated 2025-10-20T05:45:59.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T17:18:39.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Update: version from v3.0.2 to v3.1.0, indicating a new release.
    Difference
    0.0%
    Check dated 2025-09-28T10:09:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.